Literature DB >> 8210528

[Lung interstitial disease in systemic sclerosis: semiologic characteristics with high-resolution computerized tomography and comparison with other methods].

A Rotondo1, R Grassi, O Catalano, L Del Viscovo, M Vatti, M Gallo, L Bianco, L Celentano, A Brunetti, M Rivellini.   

Abstract

In 28 patients with systemic sclerosis interstitial lung involvement was investigated with high-resolution Computed Tomography (HRCT) in comparison with other diagnostic methods (respiratory function tests, lung scintigraphy and conventional radiography of the chest). The most frequent CT signs were: interlobular septal thickening, intralobular interstitial thickening, and ground-glass density. Their distribution was generally basal and posterior and high correlation was observed between the extent of lung disease and the cutaneous pattern of scleroderma. Pathological findings were present in 93% of cases: HRCT can must be considered more effective than the other methods in the evaluation of systemic sclerosis and should therefore be a fundamental diagnostic tool in the study and follow-up of interstitial diseases in the patients with systemic sclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8210528

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  3 in total

1.  Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation.

Authors:  G Valentini; A Baroni; K Esposito; C Naclerio; E Buommino; A Farzati; G Cuomo; B Farzati
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

2.  Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography.

Authors:  Maurizio Zompatori; Maria Barbara Leone; Marica Giannotta; Nazzareno Galiè; Massimiliano Palazzini; Maria Letizia Bacchi Reggiani; Lea Bono; Gian Stefano Pollini
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

3.  HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.

Authors:  M Bellia; F Cannizzaro; N Scichilone; M Riili; G Triolo; M Midiri; R Lagalla
Journal:  Radiol Med       Date:  2009-03-05       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.